Crystalline 1H-imidazo[4,5-b]pyridin-5-amine,7-[5-[ (cyclohexylmethylamino)-methyl]-1H-in dol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses

Details for Australian Patent Application No. 2006210810 (hide)

Owner Eisai R & D Management Co., Ltd.

Inventors Chase, Charles E.; Kushida, Ikuo

Agent Allens Arthur Robinson

Pub. Number AU-B-2006210810

PCT Pub. Number WO2006/083908

Priority 60/648,701 02.02.05 US

Filing date 1 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 8 March 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/083908 Priority application(s): WO2006/083908

3 April 2008 Assignment before Grant

  Eisai Co., Ltd. The application has been assigned to Eisai R & D Management Co., Ltd.

8 March 2012 Application Accepted

  Published as AU-B-2006210810

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210817-Novel adenosine A3 receptor modulators

2006210804-Data communication protocol in an automatic meter reading system